Shows
Les Affaires Brassicoles avec Leonardo Calcagno | Baron Mag🎙️Les Affaires Brassicoles #435 | bioMérieux: contrôle qualité dans les secteurs de la brasserie et des boissonsx Keg Management | Entreprise 100 % québécoiseDans un secteur en pleine croissance, où l’offre est aussi diversifiée que le goût des consommateurs, le contrôle qualité est devenu un levier essentiel pour les microbrasseries. Il permet non seulement d’assurer la constance des produits, mais aussi de renforcer la confiance des clients et de prévenir les pertes liées à des contaminations.BioMérieux est un leader mondial du diagnostic microbiologique, offrant des solutions avancées pour le contrôle qualité dans les secteurs de la brasserie, des boissons, et de l’agroalimentaire....2025-06-1338 min
MicroTalks: Conversaciones con los expertos más allá de la microbiologíaCasos clínicos: reloadedEn el último capítulo de la temporada, la Dra. Dona Benadof analiza casos microbiológicos clínicos desafiantes y comparte estrategias clave para enfrentarlos junto a la Dra. María Elvira Simian, microbióloga clínica del Laboratorio del Hospital El Salvador, y Sebastián Cifuentes, tecnólogo médico del Centro de Referencia y Diagnóstico Médico. 2025-06-0336 minMicroTalks: Conversaciones con los expertos más allá de la microbiologíaRol del químico farmacéutico en el PROA en ChileEn este nuevo episodio de #MicroTalks, conversamos con Ruth Rosales, Química Farmacéutica y Jefa de la Unidad de Farmacia Clínica UPC del Hospital Barros Luco Trudeau, sobre el impacto y la evolución de los Programas de Optimización del Uso de Antimicrobianos (PROA) en Chile.Exploramos la historia de los PROA en el país, el papel fundamental del profesional farmacéutico en la farmacia clínica, y los desafíos actuales en el contexto del uso racional de antimicrobianos, una estrategia clave frente a la resistencia bacteriana.2025-05-0821 min
Parole de leaderBioMérieux à Grenoble : focus sur la biologie moléculaireBioMérieux, une entreprise familiale devenue un leader mondial dans le domaine du diagnostic, a démarré son aventure entrepreneuriale il y a plus d’un siècle avec Marcel Mérieux, qui avait développé le premier sérum anti-tétanique.Christophe Aulard, directeur du site Biomérieux à Grenoble, nous ouvre les portes sur l’activité de ce site grenoblois dédié à la biologie moléculaire. L’activité de biologie moléculaire représente 35% de l’activité du groupe Biomérieux à l’échelle internationale, avec deux sites en France et un aux Etats-Unis.Acteur majeur de la filière Innovation Santé en ré...2025-05-0615 min
Louis Pasteur aujourd'huiBioMérieux, leader dans le diagnostic biologiqueBioMérieux est une entreprise française spécialisée dans le diagnostic Vitro. Alain Marchal, nous présente cette entreprise fondée en 1963 située près de Lyon. Sachez que BioMédreux ne s'adresse pas seulement à la biologie humaine ou vétérinaire, elle prospecte et se développe aussi dans l'industrie agroalimentaire.Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.2025-04-3005 min
GÉOPOLITIQUE PROFONDE (www.geopolitique-profonde.com)WUHAN, FAUCI, GAIN DE FONCTION : TOUTE LA CORRUPTION SANITAIRE DÉVOILÉE | GPTVLe 12 avril 2025, le Docteur Typhaine Pinsolle était l’invitée de Mike Borowski, sur Géopolitique Profonde.Le Docteur Typhaine Pinsolle est une scientifique spécialisée en microbiologie médicale, connue pour ses prises de position concernant la pandémie de COVID-19 et les vaccins, qu’elle qualifie d’armes biologiques. Forte de son expertise, elle se distingue par ses analyses scientifiques pointues, notamment concernant la protéine Spike, et se positionne en opposition à la narrative officielle.Les origines du virus de Wuhan continuent de faire débat : a...2025-04-131h 26
The Beef Podcast ShowDavid Tomas & Dr. Vikrant Dutta: STEC Detection in Beef | Ep. 122In this episode of The Beef Podcast Show, David Tomas and Dr. Vikrant Dutta from bioMérieux explore how regulation, science, and industry challenges intersect in modern beef safety management. From regulation to industry challenges, they explain what PEC, STEC, and E.coli O157:H7 mean for the beef sector—and why it matters. Explore the future of export/import regulations, evolving risks, and the impact of diagnostics to rapidly identify samples containing Shiga Toxin-producing Escherichia coli (STEC). Listen now on all major platforms!"PEC markers are associated with specific strains and provide a tru...2025-03-2640 minMicroTalks: Conversaciones con los expertos más allá de la microbiologíaPROA: Claves para optimizar el uso de antimicrobianosEn este episodio, exploramos los PROA (Programas de Optimización del Uso de Antimicrobianos) y su impacto en la lucha contra la resistencia bacteriana. Nos acompañan el Dr. Paulo Castañeda, médico cirujano de la Universidad La Salle, especialista en medicina interna, infectología y epidemiología del Instituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán”; y el Dr. Francisco Zamora, infectólogo, jefe del PROA del Hospital Barros Luco Trudeau y académico de la Facultad de Ciencias Médicas de la Universidad de Santiago de Chile. Juntos, analizamos la importancia de e...2025-03-1923 minMicroTalks: Conversaciones con los expertos más allá de la microbiologíaAntibióticos en pediatría: ¿cuándo sí y cuando no?En este episodio de MicroTalks, exploramos el manejo de las infecciones en pediatría y el uso adecuado de antibióticos en niños. ¿Cuándo es realmente necesario administrarlos y cuándo es mejor evitarlos?Para responder estas preguntas, nos acompañan dos expertas:👩⚕ Dra. Tania Cariqueo (@doctora.chiquititos) y Dra. Mirta Acuña.2025-02-1125 min
ID:IOTS - Infectious Disease Insight Of Two Specialists100. AST: Rapid Identification and Molecular AST. The BCID2 & Vitek Reveal with BioMérieuxJame is joined by Kate from BioMérieux as they take a deep dive into the BCID2 and the Vitek Reveal, 2 new devices used for rapid identification and antimicrobial susceptibility testing of blood culture isolates.Note: This episode was produced in collaboration with BioMérieux. An honorarium received from them will be donated directly to charitable causes.Message from BioMérieux: Every effort has been made to ensure the accuracy of information shared during our podcast appearances. The views expressed by our representatives are in good faith and based on the information available at the tim...2025-02-1034 min
The Poultry Podcast ShowDr. Hannes Pouseele: Data Science & Food Safety | Ep. 127In this episode of The Poultry Podcast Show, Dr. Hannes Pouseele from bioMérieux shares groundbreaking strategies for improving food safety and quality through bioinformatics and data science. Focusing on the poultry industry, he highlights practical applications, the concept of digital twins, and comprehensive approaches to managing supply chains. Discover the tools that are revolutionizing poultry health and production. Don’t miss this insightful episode—available now on all major platforms!"Timely microbiological testing ensures poultry products meet safety standards, even when results are delayed due to process timing."Meet...2025-02-0432 minID:IOTS - Infectious Disease Insight Of Two Specialists99. AST: Automated Identification & Sensitivities - the Vitek2 with BioMérieuxThis week Jame is joined by Nick and Dal from BioMérieux as they take a deep dive into the Vitek2, one of the machines available for performing Automated Antimicrobial Susceptibility Testing.Note: This episode was produced in collaboration with BioMérieux. An honorarium received from them will be donated directly to charitable causes.Message from BioMérieux: Every effort has been made to ensure the accuracy of information shared during our podcast appearances. The views expressed by our representatives are in good faith and based on the information available at the time. We accept no...2025-01-2726 minMicroTalks: Conversaciones con los expertos más allá de la microbiologíaEnterobacterales desafiantes: casos clínicos y aprendizajes claveEn este episodio de MicroTalks, la Dra. Dona Benadof analiza casos clínicos complejos de enterobacterales y bacterias gram negativas, junto al Dr. Germán Esparza, experto en resistencia antimicrobiana de la Organización Panamericana de la Salud (OPS) , y Sebastián Cifuentes, tecnólogo médico del Centro de Referencia y Diagnóstico Médico. Acompáñanos a revisar las estrategias clave para enfrentar estas infecciones desafiantes.2025-01-1536 minMicroTalks: Conversaciones con los expertos más allá de la microbiologíaPROA desde el laboratorio: estrategias para optimizar el uso de antimicrobianosEn este tercer episodio de MicroTalks, la Dra. Dona Benadof y el reconocido experto Dr. Germán Esparza profundizan en los Programas de Optimización del Uso de Antimicrobianos (PROA). Descubre el papel crucial de los laboratorios de microbiología en la lucha contra la resistencia antimicrobiana y cómo su intervención mejora los resultados clínicos y la salud pública. El Dr. Esparza, consultor de la OPS y referente en microbiología clínica, comparte estrategias clave para liderar iniciativas PROA efectivas. ¡No te pierdas esta conversación esencial para profesionales de la salud y la microbiolog2024-12-1824 min
InfectoCast#123- Diagnosticando Pneumonias - Diagnóstico Vivo com bioMérieuxEste é o primeiro episódio da série Diagnóstico Vivo, em parceria com a bioMérieuxDiscutimos tudo sobre o exame BIOFIRE®️ FILMARRAY®️ Painel Pneumonia.Quando vale a pena pedir, quando não vale, como ele funciona, suas vantagens e desvantagens.E isso dentro de um caso clínico, pra ficar mais fácil de entender.#diagnosticovivo #casoclinico #Pneumologia #examepainelpneumonia #painelpneumonia #infectocast #MedicinaInovadora #DiagnósticoRápido #Broncoscopia #KlebsiellaPneumoniae #InovaçãoMédica #Infectologia #Pneumonia #BiologiaMolecular2024-11-1538 minMicroTalks: Conversaciones con los expertos más allá de la microbiologíaLa resistencia microbiana bajo la lupa: Bacilos gram negativos (Parte 2)En este segundo episodio, continuamos profundizando en los bacilos gram negativos y exploramos los principales desafíos en la susceptibilidad y mecanismos de resistencia que enfrentan los laboratorios clínicos. Contamos con la participación de la Dra. María Elvira Simian y la Dra. Verónica Seija, quienes nos brindan una perspectiva sobre la situación internacional y abordan las polémicas y limitaciones en el ámbito clínico.2024-10-2222 minMicroTalks: Conversaciones con los expertos más allá de la microbiologíaLa resistencia microbiana bajo la lupa: Bacilos gram negativos (Parte 1) ¿Por qué los bacilos gram negativos son un desafío para la microbiología clínica? En este episodio, junto a Sebastián Cifuentes y la Dra. Verónica Seija, nos adentramos en el mundo de estas bacterias y exploramos los últimos avances en el estudio de su susceptibilidad. Desde los laboratorios hasta las infecciones en pacientes, abordamos los desafíos que plantea la resistencia antimicrobiana y las estrategias para combatirla.2024-09-1222 min
The B2B Engagement14: Leading with Customer Needs in Diagnostics (bioMérieux)Customer-Centric Marketing & the Future of Diagnostics with Bhargab BaruaIn this episode of The B2B Engagement Podcast, Gavin Finn is joined by Bhargab Barua, Vice President of Global Marketing for Integrated Clinical Solutions at bioMérieux. Bhargab shares his career journey—from product manager in India to a global marketing leader in the life sciences industry—highlighting the power of customer-centric strategies in driving market growth.Key topics include: How customer-driven marketing fuels business success in life sciences The impact of COVID-19 on the diagnostics industry and market evolution The changing role of marke...2024-07-1617 min
Debrief BourseLe debrief Bourse du 9 avril : le CAC 40 en repli avant l’inflation US.Après une séance en hausse la veille, la bourse de Paris a passé l'intégralité de la journée en territoire négatif, clôturant avec une baisse de 0,86% à 8 049 points et des volumes d'échanges de 2,87 milliards d'euros.En l'absence d'élan positif, les investisseurs font preuve de prudence en attendant les annonces de la BCE prévues ce jeudi, ainsi que les chiffres de l'inflation aux États-Unis demain, lesquels auront une incidence sur les futures décisions de la Fed.Du côté des valeurs en hausse, Eurofins Scientific se hisse au haut du tableau avec une...2024-04-0902 minDebrief BourseLe debrief Bourse du 3 avril : le CAC 40 repart de l'avantAprès la baisse d'hier, le CAC 40 est reparti du bon pied et finit cette séance en hausse de 0,29% vers les 8.153 points et 3,5 milliards d'euros échangés. Les marchés n'ont pas trop mal réagi aux bons chiffres de l'enquête ADP sur l'emploi américain. 184.000 postes ont été créés en mars, bien au-dessus des 150.000 attendus par le consensus Briefing, ce qui tend à démontrer une nouvelle fois que la vigueur de l'économie US ne rend pas urgente une baisse des taux.Les marchés américains s'inscrivent également en hausse modérée à 17h45 : le Dow Jonest e...2024-04-0302 min
Transformation LeadersThierry Bernard, CEO of QIAGEN: Transforming Beyond Boundaries"Transforming Beyond Boundaries" – Thierry Bernard, CEO of QIAGENIt's easy to believe a transformation is a once-in-a-decade event. This mindset is fundamentally flawed. True change isn't about grand, singular moments but the continuous evolution that challenges and reshapes our approach to leadership and innovation.In reality, Thierry Bernard's journey with QIAGEN and all QIAGEN’ers exemplifies the power of relentless transformation. Amidst the pandemic's chaos, QIAGEN leveraged the crisis not just as a challenge but as a profound opportunity for growth and innovation. It was an awakening for 6,000 QIAGEN’ers worldwide, proving that transformation is an ong...2024-03-2734 min
Pause – Alexandre MarsStéphane Bancel, PDG de ModernaPAUSE, émission présentée par Alexandre Mars.
Invité : Stéphane Bancel, le PDG de Moderna.
Une pause avec celui que l’on présentait il y a peu comme le français qui
va sauver le monde.
Originaire de Marseille, il choisit d’évoluer au sein du monde pharmaceutique après son diplôme en génie chimique de l'École Centrale de Paris. Passé par bioMérieux et le groupe américain Lilly, c’est en 2011 qu’il se lance dans la grande aventure de Moderna. Si les premiers temps sont compliqués, la Covid mar...2023-12-1000 min
PAUSE - le podcast d’Alexandre MarsStéphane Bancel, PDG de ModernaCette semaine, je vous propose une pause avec celui que l’on présentait il y a peu comme le français qui va sauver le monde. Originaire de Marseille, il choisit d’évoluer au sein du monde pharmaceutique après son diplôme en génie chimique de l'École Centrale de Paris. Passé par bioMérieux et le groupe américain Lilly, c’est en 2011 qu’il se lance dans la grande aventure de Moderna. Si les premiers temps sont compliqués, la Covid marquera un tournant colossal pour la biotech et le guidera jusqu’en...2023-11-291h 31
Everybody Hates PharmaThe Future of Pharma Marketing with Hazem SayedWelcome to another insightful episode of the Pharma Sales & Tech Podcast by Platforce. In this edition, we have Hazem Sayed, a seasoned marketing leader at bioMérieux, taking us on a journey through the ever-evolving landscape of pharmaceutical marketing. Get ready to explore the power of data-driven strategies and the changing dynamics within the pharmaceutical industry.Episode Highlights:The Pharma Evolution: Hazem sheds light on how pharmaceutical marketing is adapting to the digital age and leveraging data-driven strategies for improved engagement.Market Access Matters: Discover the growing significance of market access and the s...2023-09-0836 min
Funny Medicine PodcastFunny Medicine Episode 6: GastroenteritisToday, we talk about the nasties... Gastroenteritis aka stomach bugs. How we feel about them, our experiences with them especially being moms and Yvy being a Pediatrician too. #funnymedicinepodcastInstagram @FunnyMedicinePodcast TikToks @FunnyMedicinePodcast Email: FunnyMedicine305@gmail.com Sources:https://go.biomerieux-usa.com/gastrointestinal-diagnostic-solutions/?utm_source=google-ads&utm_medium=Search&utm_campaign=Panel-GI&gclid=Cj0KCQjwtO-kBhDIARIsAL6LorcO5jsktUaOAx9TBaGVyioyxjXXJCxk32lYwY9_M5Y0KZlMRZpCYeQaArSZEALw_wcB2023-07-1146 min
HLTH Forward PodcastFuture of Diagnostics: Thierry Bernard, Chief Executive Officer, QiagenDiagnostics play a critical role in healthcare. Predicting and preventing diseases early can reduce healthcare costs, reduce emotional stress, and improve precision care and medicine. The future of diagnostics lies at the intersection of good governance, innovation, social impact, and humanity.The global Digital Diagnostics market size was valued at USD 458.57 million in 2021-2022 and is expected to expand at a CAGR of 26.23% during the forecast period, reaching USD 1855.5 million by 2030.In this episode, I am in conversation with Thierry Bernard, Chief Executive Officer at Qiagen. We discuss the importance of good diagnostics in our...2023-06-2633 min
The Canadian Breakpoint12. S2 Episode 2: Molecular DiagnosticsDr. Rupeena Purewal invites Dr. Marthe Charles, Medical Microbiologist and Infectious Diseases Specialist from Vancouver, BC to discuss new molecular diagnostics.Link to some of the diagnostic tools discussed: bioMérieux | Pioneering Diagnostics (biomerieux.com)2023-04-2044 min
Le grand entretienAlexandre Mérieux, PDG de bioMérieux - 04/04Alexandre Mérieux, PDG de bioMérieux, était l'invité de Laure Closier et Christophe Jakubyszyn dans Good Morning Business, ce mardi 4 avril. Il a raconté l'histoire de sa boîte, spécialisée dans les test médicaux, et abordé le développement de Spotfire, une nouvelle plateforme de diagnostic aux États-Unis, sur BFM Business. Retrouvez l'émission du lundi au vendredi et réécoutez la en podcast.
2023-04-0407 min
Cannabis Tech TalksEpisode 117: Cannabis Microbiology Testing with bioMérieuxAspergillus, yeasts, molds, and any number of other pathogens could find their way into cultivation facilities or storage rooms. To discuss some of the science and tech involved in the microbiology testing space, Cannabis & Tech Today spoke with Patrick Bird, senior manager for Scientific Affairs at bioMérieux, on-site at MJBizCon 2022.Cannabis Tech Talks are brought to you thanks to the support of Polyscience. Discover how Polyscience is changing the world of temperature control by visiting https://Polyscience.com.2023-02-1617 min
BreakpointsStewardship StrugglesEpisode Notes
Drs. Valerie Vaughn (@ValerieVaughnMD), Jason Newland (@JasonGNewland) and Libby Dodds Ashley (@The_Real_LDA) join Dr. Erin McCreary (@ErinMcCreary) for a discussion on how to harness the power of data to move through those common stewie struggles. Tune in for a review of common barriers, the art of communication within stewardship, and more!
This podcast is sponsored by bioMérieux.
Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About
Twitter: @SIDPharm (https://twitter.com/SIDPharm)
Instagram: @SIDPharm (https://www.instagram.com/sidpharm/)
Facebook: https://www.facebook.com/s...2023-01-201h 16
MIEUX, le podcast qui interroge le monde du travailComment l'entreprise peut contribuer à changer le monde ? Alan Fustec Goodwill management ; Jean Moreau Phenix et Remi Tilmont bioMérieuxAvec l'accélération du réchauffement climatique (et ses effets visibles dans nos vies), avec la crise sanitaire liée à la COVID, quelque chose a profondément changé dans nos sociétés.
Nous nous penchons avec intérêt sur les questions environnementales.
Nous nous demandons, individuellement ou collectivement, ce que nous pouvons faire à notre niveau. Nous questionnons notre rapport au travail, et, par voie de conséquence, le rapport de notre entreprise avec le monde dans lequel elle s'inscrit.
Quel est le rôle de notre entreprise dans le monde ? Quels
sont ses imp...2023-01-1222 min
SCCM PodcastSCCM Pod-468: When Should Antibiotics Be Used to Treat Respiratory Infections?Although only a small number of patients hospitalized with COVID-19 present with a secondary bacterial pneumonia, a large percentage are unnecessarily treated with antibiotics. Pamela M. Peeke, MD, MPH, FACP, FACSM, is joined by George Sakoulas, MD, to discuss how physicians and hospitalists can identify when antibiotics are unnecessary for hospitalized patients with moderate to severe respiratory infections. Dr. Sakoulas is chief of infectious disease at Sharp Rees-Stealy Medical Group in San Diego, California, and an adjunct professor in the Division of Host-Microbe Systems and Therapeutics Center for Immunity, Infection, and Inflammation at the University of California San Diego School...2022-12-2722 min
Food Safety MattersEp. 134: Sandra Eskin: How USDA-FSIS is Tackling Salmonella in PoultrySandra Eskin was appointed Deputy Under Secretary for Food Safety at the U.S. Department of Agriculture (USDA) in March 2021. In this role, Sandra leads the Office of Food Safety, overseeing the Food Safety and Inspection Service (FSIS), which has regulatory oversight for ensuring that meat, poultry, and egg products are safe, wholesome, and accurately labeled. Prior to joining USDA, Sandra was the Project Director for Food Safety at The Pew Charitable Trusts in Washington, D.C. for over 10 years, and also served as the Deputy Director of the Produce Safety Project (PSP) from 2008–2009, a Pew-funded initiative at...2022-12-131h 06
Xtalks Life Science PodcastFirst Gene Therapy Approved for Hemophilia B + World AMR Awareness WeekIn this episode, Ayesha shared news about the FDA approval of the first gene therapy for the rare blood disorder Hemophilia B. The approval was awarded to CSL Behring’s Hemgenix, a single-dose gene therapy that delivers a working copy of the gene that codes for the Factor IX protein that is deficient, or made in insufficient amounts, in patients with Hemophilia B. The therapy is now officially the world’s most expensive drug at $3.5 million per dose. Hear more about the therapy and how the high price tag of the new drug is actually lower than the cost of t...2022-11-3034 min
Editors in ConversationHow Can Clinical Microbiology Labs Contribute to Antimicrobial Stewardship? (JCM ed.)Deciding how extensively to work up and report respiratory cultures is the worst. There are useful guidelines on how to approach this. But, in my experience, very few laboratories strictly follow these guidelines. That can be because of concerns about under-reporting pathogens or about over-reporting microbiota, or it can be the result of pressure from clinical staff to report more organisms than the guidelines suggest. Today, we’ll be talking with two guests about their study on how over-reporting of organisms from respiratory tract cultures can lead to over treatment with antimicrobials. Guests: Dr. Sarah Parker, pe...2022-11-1942 min
The Frankie Boyer ShowCANNABIS Talk A to Z: Patrick Bird of bioMerieux and Richard Steinhart of CBD UnlimitedPatrick Birdhttps://www.biomerieux.com/Richard Steinharthttps://www.cbdunlimited.com/Patrick Bird is a Sr. Manager of Scientific Affairs at bioMérieux, collaborating with industry and regulatory agencies to develop and advance science-based standards and regulations. Pat has 18+ years’ experience in the validation of microbiology analytical test methods coordinating more than a 100 validations studies following AOAC, ISO, Health Canada and EPA validation guidelines. Pat served as the primary author for the microbiology chapter (Laboratory Safety and Compliance Testing for Microorganism Contamination) in the Cannabis Laboratory Fundamentals textbook and has presented numerous webinars and...2022-11-1139 min
European Pharmaceutical Review podcastEPR Podcast Episode 16 – Evolving QC for Cell & Gene Therapy – Félix Montero Julian and Thomas Jones, bioMérieuxIn this episode, Félix Montero Julian, the Scientific Director for the Healthcare Business of bioMérieux and Thomas Jones, Cell & Gene Therapy Business Senior Director at bioMérieux discuss the evolving needs of quality control (QC) for cell and gene therapy (CGT) and how these developments are supporting efforts to scale up manufacturing.
What’s new in the cell and gene therapy landscape?
“For me the most exciting thing is the rapid approval we are seeing for new indications and the expansion to second-line use for existing cell therapy products,” explains Tom Jones.
This ye...2022-11-0127 minDebrief BourseLe debrief Bourse du 18 octobre : 4e séance de hausse consécutive pour le CAC 40Quatre à la suite ! Quatrième séance de hausse consécutive pour le CAC 40 qui termine en progression de 0,44% à 6.067 points tout pile mais, là aussi, un peu à l'image d'hier, cela se fait avec des volumes qui restent anémiques, seulement 2,8 milliards d'échangés.Outre-Atlantique aussi, l'optimisme est là avec des publications de résultats trimestriels solides de la part d'entreprises comme Goldman Sachs ou encore Johnson & Johnson. A 17h45, le Dow Jones grimpe de 0,6% vers les 30.369 points et le Nasdaq est, lui,à +0,3% vers les 10.706 points.Valeurs en hausseC'est McPhy Energy qui se distingue, survola...2022-10-1802 min
Public Health Epidemiology ConversationsInfectious Diseases And Public Health, With Andrea Prinzi, PhD, MPH If infectious diseases and public health is your thing then you’ve come to the right place! Joining us on this episode is Clinical Microbiologist, Science Communicator, and Infectious Diseases Specialist, Dr. Andrea Prinzi. Dr. Prinzi studied at the University of Colorado and went on to develop and run several microbiology educational programs. In 2018, she was handed the American Society for Clinical Pathologists 40 Under Forty award, and today, she serves as Medical Science Liaison at bioMérieux. 2022-10-1832 min
Playing FTSEUK's KamiKwazi Budget & 6 Stocks From Our Watchlists!Our archers pick up their bows and arrows and take aim at this week’s stories. Only on the PlayingFTSE show!
Steve and Steve are in this week to talk about stories. And they’re starting with the small stuff. It’s the UK’s latest economic plan.
This has been top of mind for Steve W for a few days now and he’s been trying to figure his way around it. He’s not a fan, but he thinks it’s been badly covered in the mainstream media. What does it mean for the Steves and...2022-10-021h 02
espaciolibreCristian Tehres, confronta a CEO de farmacéutica Moderna sobre la vacuna Covid19El diputado Cristian Terhes, confronta al CEO de la farmacéutica Moderna.
Cristian Terhes es un político rumano que actualmente se desempeña como miembro del Parlamento Europeo por el Partido Nacional Campesino Demócrata Cristiano, después de ser elegido en el Partido Socialdemócrata.
Stéphane Bancel es un empresario multimillonario francés . Es el director ejecutivo (CEO) de la compañía farmacéutica y biotecnológica estadounidense Moderna , conocida por su vacuna COVID-19 .
Antes de unirse a Moderna, Bancel fue director ejecutivo de la empresa francesa de diagnóstico BioMérieux...2022-09-1500 min
Pump / Dump49: PUMP / DUMP #73 : Les Tops & Flops de la semaineChaque vendredi, Zonebourse vous propose une sélection des plus grosses variations de la semaine, à la hausse comme à la baisse ! Les sociétés sélectionnées affichent des capitalisations supérieures à 1 milliard de dollars, et sont accessibles aux européens sur certains courtiers.
Pinduoduo, Nutanix, Snap, Cameco, Unicredit, Okta, Verbund, Eramet, BioMérieux, et Nvidia sont à l'honneur cette semaine !
2022-09-0202 min
Blunt BusinessBioMérieux with Maria McIntyreBioMérieux with Head of Cannabis Safety Operations Maria McIntyre today on Blunt Business only on The Cannabis Radio. Our next guest represents a world leader in the field of in-vitro diagnostics for over 55 years, bioMérieux is present in 44 countries and serves more than 160 countries with the support of a large network of distributors.My guest works with key opinion leaders across the country to find solutions that mitigate inherent risk factors throughout the supply chain for both the Cannabis and Hemp industries. bioMérieux was recently awarded the 2022 Food Safety Innovation Award for Predictive Diagnostics fro...2022-08-2422 min
Alles auf Aktien – Die täglichen Finanzen-NewsCurevac schlägt zurück und Lichtblick bei Lieferdiensten7.7.2022 - Der tägliche Börsen-Shot
In der heutigen Folge „Alles auf Aktien“ berichten die Finanzjournalisten Daniel Eckert und Anja Ettel über große Hoffnung für kleine Werte, eine überraschende Wende bei den Lieferdiensten und den Dreifach-Blues der PC-Aktien. Außerdem geht es um Evotec, bioMérieux, Rohstoffe, HelloFresh, Just Eat Takeaway, Amazon, Delivery Hero, Adidas, HP, Intel, Dell, Biontech, Curevac, Pfizer, GSK, Siltronic, Jungheinrich, Thyssenkrupp, Lanxess, Dürr, TAG Immobilien, Eckert & Ziegler, Encavis, PNE, SMA Solar, BayWa, Xtrackers MSCI Europe Small Cap (WKN DBX1AU), Invesco STOXX Europe Small 200 (WKN A0RGCN), SPDR Russell 2000 US Small Cap (WKN A1XFN1) u...2022-07-0717 min
Invent: Life SciencesCell Therapy Manufacture: How to scale the manufacture of living drugs
Following our first episode of two focusing on cell and gene therapies, outlining the promise and practicalities of delivering curative therapies for chronic diseases, we now focus on cell therapies - so called ‘living drugs’ that are both as powerful as they are complex. Despite the impressive trials and life-changing impacts at the individual level, it’s still not possible to manufacture cell therapies at scales that could benefit a wider range of patients. So what are the differences between cell therapies and conventional medicines that make them so difficult to manufacture? Can we redeploy hardware and learnings from other...2022-07-0546 minDebrief BourseLe debrief Bourse du 4 juillet : le CAC 40 démarre juillet en petite hausse, sans Wall StreetLa première séance de la première semaine de juillet commence avec un CAC 40 en légère hausse : +0,4% vers les 5955 points et 2,1 milliards d'euros échangés.C'est peu me direz-vous, et vous aurez raison c'est parce que Paris a dû naviguer sans sa boussole américaine, les marchés US étant fermés pour la fête nationale.Côté statistiques, on a pris connaissance d'un indice Sentix du moral des investisseurs au plus bas depuis 2020 en juillet au sein de la zone euro. A noter que mercredi, on aura droit au compte-rendu du c...2022-07-0402 minThe Frankie Boyer ShowCannabis A to Z - Maria McIntyre of bioMérieux, Vince Sanders of American Shaman, Prof_BudzMaria McIntyre, Head of Cannabis Safety Operations, bioMérieuxgo.biomerieux.com/us/cannabisMaria McIntyre a trailblazer in cannabis microbiology, has exhibited a lifelong enthusiasm for human health and public safety reflected in science, education and innovation. A world leader in the field of in vitro diagnostics for over 55 years, bioMérieux provides diagnostic solutions which determine the source of disease and contamination to improve patient health and ensure consumer safety. https://www.biomerieuxconnection.com/+ originally aired March 4, 2022Vince Sanders of American Shaman & Prof_BudzVince Sanders founded CBD American Shaman in Ma...2022-06-2439 min
IppocraTechEp. 17 - Benefici di BioFire Pneumonia plus in AMS, con parte specifica in merito a Pronto SoccorsoOspite della nuova puntata di Ippocratech è la dottoressa Novella Carannante, Infettivologa all’Ospedale Cotugno di Napoli, con la quale parleremo del Suo impegno nell’utilizzo del test sindromico rapido anche in Pronto Soccorso per la diagnosi di pazienti con sospetta polmonite. Ascolta gli altri episodi su cliccando qui: Approfondimenti sulla diagnostica | bioMérieux Italia (biomerieux.it)See omnystudio.com/listener for privacy information.2022-05-3008 minDebrief BourseLe debrief Bourse du 12 mars : le CAC 40 limite la casse en fin de séanceDécidément, rien ne dure en ce moment à la Bourse de Paris. Après deux séances dans le vert, le CAC 40 repart à la baisse, on a toutefois limité la casse avec un repli qui a été plus prononcé en cours de séance mais qui s'établit finalement à -1,01% vers les 6.206 points et près de 4,6 milliards d'euros échangés à la clôture.Aux Etats-Unis, après une nouvelle baisse hier, c'est une situation contrastée aujourd'hui sur fond de prix à la production en ligne avec les attentes mais d'inscription hebdomadaires au chômage plus fortes que prévu. Le Do...2022-05-1202 minDebrief BourseLe debrief Bourse du 12 avril : Paris a rebondi en fin de séance mais finit quand même dans le rougeD'abord en fort repli, la Bourse de Paris a finalement rebondi portée par une inflation moins forte que prévu en mars aux Etats-Unis hors énergie et alimentation.Alors que le CAC 40 perdait presque 2% dans la journée, il termine sur une baisse de 0,28% vers les 6537 points.Du côté des valeurs,Après avoir été largement chahutées hier, le luxe rebondit grâce à un assouplissement des mesures prophylactiques en Chine, principal marché du secteur. LVMH avance de 1,77%. Le groupe publie ce soir ses ventes pour le premier trimestre. Hermès progresse de 0...2022-04-1202 min
UBeeRadio - il podcast dei piccoli birrifici indipendenti italianiUBeeRadio - puntata 3Terza puntata di UBeeradio, podcast dei piccoli birrifici indipendenti. Puntata finale riguardo l'evento BeerAttraction - Rimini, con news e novità sul mondo birrario italiano. Ospiti: Agostino Arioli e le aziende MR-Malt, Pink e Biomerieux2022-04-1123 minDebrief BourseLe debrief Bourse du 28 mars : le CAC 40 démarre la semaine en hausseEspérant des avancées dans les discussions entre la Russie et l'Ukraine cette semaine, le marché français commence la semaine en hausse avec un CAC 40 qui termine la journée à +0,54% vers les 6589 points et 3,5 milliards d'euros échangés. C'est pas mal mais un peu décevant quand on voit qu'on était à +2% à la mi-journée. Le tout dans un contexte de hausse des taux alors que l'OAT à 10 ans a retrouvé le seuil de 1% pour la première fois depuis 2017.Outre-Atlantique, c'est plus hésitant avec même un Dow Jones qui se replie de 0,5% à 17h45 vers les 34.676 points a...2022-03-2802 minDebrief BourseLe debrief Bourse du 22 mars : malgré les vents contraires, le CAC 40 finit dans le vertIl a eu bien du mérite de monter le CAC 40 aujourd'hui. L'indice finit la journée sur une hausse de 1,17% vers les 6659 points grâce surtout à la bonne tenue de Wall Street, dans des volumes plutôt faibles étant donné le contexte actuel : 3,7 milliards d'euros échangés.Pourtant, la guerre en Ukraine se poursuit de plus belle, les taux longs montent et Jerome Powell, le patron de la Fed n'a pas exclu une augmentation des taux de 0,5% lors de l'une des prochaines réunions du Comité monétaire alors que l'inflation reste beaucoup trop forte aux Etats-Unis...2022-03-2202 min
TopMedTalkPart 6 Know AKI and say no to acute kidney injury for patients | POQI renal injuryTopMedTalk's essential series on acute kidney injury continues, supported by the "Know AKI campaign" – a bioMérieux global campaign to raise awareness about AKI. For part one of the series follow this link: https://topmedtalk.libsyn.com/part-1-know-aki-and-say-no-to-acute-kidney-injury-for-patients-perioperative-renal-injury In this podcast you will discover how The Perioperative Quality Initiative (POQI) focuses upon renal injury. How do we identify patients early? How do we treat the condition? What should out approach to biomarkers be? What are we looking for when it comes to urine output? Make sure you check out POQI's website here: htt...2022-03-2137 minTopMedTalkWorld Kidney Day, "To know AKI is to say no to AKI" | TopMedTalkThis podcast is in addition to a series supported by the "Know AKI campaign", a bioMérieux global campaign to raise awareness about AKI. Go here for part one: https://www.topmedtalk.com/part-1-know-aki-and-say-no-to-acute-kidney-injury-for-patients-perioperative-renal-injury/ It includes contributions from Dan Engelman, Medical Director of the Heart, Vascular and Critical Care Units at Baystate Medical Center, Associate Professor of Surgery at The University of Massachusetts-Baystate, and an Associate Professor-Adjunct at Tufts University School of Medicine and Sandra Kane-Gill, Professor of Pharmacy and Therapeutics at the University of Pittsburgh School of Pharmacy, secondary appointments in the School of Medicine in the Clinical T...2022-03-1014 minTopMedTalkPart 5 Know AKI and say no to acute kidney injury for patients | Post-Operative Acute Kidney Injury RoundtableHow should we best monitor and treat acute kidney injury (AKI)? Where is the information leading our best practitioners to? How can monitoring incidences of AKI help to reduce it? This podcast is Part 5 in a series supported by the "Know AKI campaign", a bioMérieux global campaign to raise awareness about AKI. For part one go here: https://topmedtalk.libsyn.com/part-1-know-aki-and-say-no-to-acute-kidney-injury-for-patients-perioperative-renal-injury For part two go here: https://topmedtalk.libsyn.com/part-2-know-aki-and-say-no-to-acute-kidney-injury-for-patients-perioperative-aki-recomendations-and-research-priorities-from-adqi-24poqi-7 Part three is here: https://topmedtalk.libsyn.com/part-3-know-aki-and-say-no-to-acute-kidney-injury-for-patients-health-systems-perspectives-in-aki And part four i...2022-03-0739 minTopMedTalkPart 4 Know AKI and say no to acute kidney injury for patients | Andy Shaw on Acute Kidney Injury (AKI) biomarkersThis podcast is part 4 in a series which is supported by the "Know AKI campaign", a bioMérieux global campaign to raise awareness about AKI. For part one go here: https://topmedtalk.libsyn.com/part-1-know-aki-and-say-no-to-acute-kidney-injury-for-patients-perioperative-renal-injury For part two go here: https://topmedtalk.libsyn.com/part-2-know-aki-and-say-no-to-acute-kidney-injury-for-patients-perioperative-aki-recomendations-and-research-priorities-from-adqi-24poqi-7 And for part three follow this link here: https://topmedtalk.libsyn.com/part-3-know-aki-and-say-no-to-acute-kidney-injury-for-patients-health-systems-perspectives-in-aki Acute kidney injury (AKI) is an important topic for anyone practicing value based care, here we learn how research is developing and where the debate is at as regards b...2022-02-2111 min
European Pharmaceutical Review podcastFuture of ATMPsIn our previous advanced therapy medicinal products (ATMPs) episode Jérôme Larghero, Director of the Department of Biotherapies and the MEARY Center for Cell and Gene Therapy in the Hôpital Saint-Louis, AP-HP, and Julien Textoris, Vice President of Global Medical Affairs, Immunoassays and host response at bioMérieux, discussed the importance of collaboration in developing cell and gene therapies and the processes and quality controls that support their manufacture. In this final episode they join us once again to explain what makes these challenges worth overcoming and the key areas of development expected to shape the future of t...2022-02-1629 minTopMedTalkPart 3 Know AKI and say no to acute kidney injury for patients | Health systems perspectives in AKI"Kidney disease ... is clearly a public health concern" Health systems perspectives in acute kidney injury, this podcast is part 3 in a series which is supported by the "Know AKI campaign", a bioMérieux global campaign to raise awareness about AKI. For part one go here: https://topmedtalk.libsyn.com/part-1-know-aki-and-say-no-to-acute-kidney-injury-for-patients-perioperative-renal-injury For part two go here: https://topmedtalk.libsyn.com/part-2-know-aki-and-say-no-to-acute-kidney-injury-for-patients-perioperative-aki-recomendations-and-research-priorities-from-adqi-24poqi-7 This piece is one of the highlights of both EBPOM London and EBPOM Dingle/Chicago where it provoked much discussion amongst the delegates. What does the data and e...2022-02-0711 min
ACEP Frontline - Emergency MedicineThe New Flu in the COVID PandemicCOVID-19 has forever changed respiratory pathogen epidemiology and ED diagnostic strategy. In this episode, Dr. Charles Cairns discusses the role of syndromic respiratory panels, along with PCT-guided therapy, to address this new "flu season".
This episode is made possible with support from BioMerieux Inc.2022-01-2424 minDebrief BourseLe Debrief Bourse du 13 janvier : le CAC 40 repart à la baisseAprès deux séances de rebond le CAC 40 repart à la baisse aujourd'hui et termine la séance à -0,5% vers les 7201 points et presque 4 milliards d'euros échangés. Aux Etats-Unis, les indices évoluent en ordre dispersés. Si le Dow Jones progresse de 0,5% à 17h45 vers les 36.474 points, le Nasdaq est, lui, à nouveau sous pression et cède 0,45% vers les 15.119 points. Les investisseurs se préparent désormais pour la saison des résultats qui s'ouvre demain avec la publication des banques JPMorgan Chase, Citi et Wells Fargo.Valeurs en hausseEt c'est Sopra Steria qui domine le SBF 120 aujo...2022-01-1302 minTopMedTalkPart 1 Know AKI and say no to acute kidney injury for patients | Perioperative Renal InjuryThis piece has been supported by the "Know AKI campaign" – a bioMérieux global campaign to raise awareness about acute kidney injury. It features a wide selection of clips on the subject of acute kidney injury, restrictive versus liberal fluid therapy and the trials we've seen in recent years which have revitalized debate and learning. The clips used come from the following podcasts: Michelle Chew's clip comes from here: EUROANAES2019 | Michelle Chew http://www.topmedtalk.com/euroanaes2019-michelle-chew/ Andy Shaw's clip comes from here: SCA | Improving your practice http://www...2022-01-1052 minDebrief BourseLe debrief du 17 décembre : le CAC 40 recule de 0,9% sur la semaineIl avait gagné 1,12% hier, il reperd 1,12% aujourd'hui. Rattrapé par l'inquiétude, le CAC 40 clôture dans le rouge autour des 6.926 points avec de gros volumes 8 milliards d'euros échangés, normal en cette journée des 4 sorcières où options et contrats à terme arrivent à expiration à 16 heures. Sur la semaine le CAC recule de 0,9%Le coup de froid est venu de Wall Street avec un Nasdaq qui a cédé 2,5% à la clôture, les valeurs de la tech US étant, avec un peu de retard, pénalisées par les annonces d'une politique monétaire moins accommodante de la Fed.D'aill...2021-12-1702 minEuropean Pharmaceutical Review podcastEPR Podcast Episode 7 – Collaboration in ATMP development – Jérôme Larghero and Julien Textoris, bioMérieuxCollaboration has been a huge part of the COVID-19 pandemic response, but it is also hugely important in the development of various other therapeutics. In the second episode in our advanced therapy medicinal products (ATMPs) series Jérôme Larghero, Director of the Department of Biotherapies and the MEARY Center for Cell and Gene Therapy in the Hôpital Saint-Louis, AP-HP, and Julien Textoris, Vice President of Global Medical Affairs, Immunoassays and host response at bioMérieux, discuss the importance of collaboration between academia and industry in the development of ATMPs.
What is the MEARY Center?
The...2021-12-1526 min
Editor's Top PicksPart 1 Know AKI and say no to acute kidney injury for patients | Perioperative Renal InjuryThis piece has been supported by the "Know AKI campaign" – a bioMérieux global campaign to raise awareness about acute kidney injury. It features a wide selection of clips on the subject of acute kidney injury, restrictive versus liberal fluid therapy and the trials we've seen in recent years which have revitalized debate and learning. The clips used come from the following podcasts: Michelle Chew's clip comes from here: EUROANAES2019 | Michelle Chew http://www.topmedtalk.com/euroanaes2019-michelle-chew/ Andy Shaw's clip comes from here: SCA | Improving your practice http://www...2021-12-0252 minDebrief BourseLe debrief Bourse du 26 novembre : Black Friday boursierL’émergence d'un nouveau variant du Covid-19 en Afrique du Sud faisant craindre une résistance élevée aux vaccins a brutalement ravivé l'aversion au risqueRésultat le CAC 40 affiche sa pire séance depuis plus d’un an et efface tous les gains accumulés ce mois-ci. L’indice termine sur une baisse de 4,75% vers les 6739 points dans un volume d’échanges très élevé : plus de 7 milliards d’euros échangés ce soir.Du côté des valeurs,Les reculs sont sans surprise très importants pour le secteur de l’aéronautique avec Airbus qui lâc...2021-11-2602 minEuropean Pharmaceutical Review podcastEPR Podcast Episode 5 – ATMP manufacturing and QC – Rey Mali, Accellix and Félix Montero-Julian, bioMérieuxCell and gene therapies, types of advanced therapy medicinal products (ATMPs), are an exciting emerging class of therapeutics offering potentially huge therapeutic benefit. So far, more than 100 cell and gene therapies have been approved in markets worldwide and many more are under development.
Cell therapies have shown promise in treating diseases such as cancer, where chimeric antigen receptor (CAR) T-cell therapies have already transformed care for haematological malignancies, and gene therapies offer a potentially one-time curative treatment for genetic disorders.
Yet despite their potential, there are challenges facing cell and gene therapies. In this podcast...2021-11-1027 min
#ChatsWithChaudhrey the Podcast#ChatsWithChaudhrey with Brendan Tindall, bioMérieux on Recombinant Factor C (#rFC) for Bacterial Endotoxin Testing (#BET).I caught with Brendan Tindall, Global Solutions Manager – ENDONEXT, Industrial Microbiology, bioMérieux last October to learn more about Recombinant Factor C (#rFC) for Bacterial Endotoxin Testing (#BET).You can find out more here https://lnkd.in/eV-Je-AYou can view many more interviews and demos from many other industry experts across Pharma, Bio-Pharma and Life Science on my YouTube channel RSK Life Science Media https://www.youtube.com/channel/UC9vdET2xLlGweqveW6JmQdQ#rFC, #endotoxintesting, #BET2021-10-2311 min
Editor's Top PicksAcute Kidney Injury | Post-Operative AKIHow should we best monitor and treat acute kidney injury (AKI)? Where is the information leading our best practitioners to? How can monitoring incidences of AKI help to reduce it? With thanks to our sponsor Biomerieux, who helped bring this podcast to you for free, in advance of the annual general meeting of the American Society of Anesthesiologists (ASA). TopMedTalk will be live streaming from the event, checkout www.ebpom.live.org for more details. You can watch a video of the lecture in the on demand section of the EBPOM Education Hub (www.live...2021-10-0739 min
Grassroots MarketingBioMerieux with Ben Pascal (Mj BizCon)BioMerieux with Ben Pascal today on Grassroots Marketing only on Cannabis Radio. At bioMerieux, they have a global corporate mission to protect human health and ensure consumer safety. bioMerieux provides one-of-a-kind microbiology solutions to expand cannabis safety and science providing diagnostic solutions and biotechnology to determine the source of microscopic pathogens and contamination within cannabis products all along the supply chain from seed to flowers, edibles, and other consumables. Their products are used across the globe for detecting microorganisms in cannabis, agri-food, nutraceuticals, beer, and wine to meet state and federal regulations. They'd like to generate awareness around the topic...2021-10-0618 min
The IT Experience Podcast69. Steps to creating Human Centric IT, with bioMérieuxHuman-Centric IT is a topic we frequently talk about in ITSM and IT Service Delivery. Human-Centric IT puts your end-users at the centre of Experience Management and all IT touchpoints. However, wouldn't it be great if there was an example of a companies journey to creating this kind of culture?
Oh wait, there is!
BioMérieux is a French multinational biotechnology company, which has existed for over 50 years. Their end-user base ranges from young tech-savvy new starters to employees who have been with the company since the beginning. BioMérieux wanted to improve how they de...2021-09-3015 min
IppocraTechEp. 8: Sepsi - Eccellenza e Innovazione nel settore Life ScienceIl nuovo episodio di IppocraTech ci porta alla scoperta dell’approccio sindromico e dei benefici del test rapido BioFire® BCID2 per la diagnosi di infezione del torrente circolatorio e della sepsi. Il test è stato candidato al concorso Life Science Excellence Award 2021e classificato da una giuria di personalità di rilievo del settore tra i top dieci nella categoria Best Innovative Device/Technology of the Year. Perché il test BCID2 è così innovativo? A quali bisogni clinici risponde? E a chi sono diretti i benefici dell’approccio sindromico? Ne parliamo con la dott.ssa Valeria Zucchelli, Adriatic Medical Af...2021-09-2212 min
PAUSE - le podcast d’Alexandre MarsAlain Mérieux, Fondateur de bioMérieux, Président de la Fondation Mérieux, Président de l'Entreprise des PossiblesSurnommé "l’Abbé Pierre, version entrepreneur", Alain Mérieux est à la tête d’un empire pharmaceutique qu’il a bâti il y a quelques décennies. Issu d’une famille de biologistes, scientifiques, il poursuit la voie noble, et avec la manière, en faisant rayonner l’expertise française à l’international. Classé 10e plus grande fortune de France, Alain Mérieux met son pouvoir financier au service du bien commun. Engagé, il l'est non seulement politiquement auprès de sa belle région lyonnaise, mais aussi à travers sa fondation éponyme. Sans compter ses engagements quotidiens, dont l’Entreprise...2021-09-2148 min
Future of Work PioneersMarcello Damiani: Innovation in Biotechnology with AI (Episode 47)Dr. Harpreet Singh interviews Marcello Damiani, the Chief Digital & Operational Excellence Officer at Moderna. Marcello has 20 years of experience in IT and business processes and leads Moderna’s digital strategies. Prior to joining Moderna, Marcello served leadership roles as Group CIO at bioMérieux and as Sr. Director of Global Networks at Motorola.2021-09-0726 min
SICM's PodcastTALKSHOW S03E02 Part 2:Decisions in Choosing the Right Antibiotic Treatment for Critical LRTI Infectious during COVID-19 EraSeries 3, Episode 2 of our AMS-SICM Talkshow!"Decisions in Choosing the Right Antibiotic Treatment for Critical LRTI Infectious during COVID-19 Era"Date: 28th August, 2021, Saturday 2:30PMOur Host:Dr Jolin Wong(Intensivist/Anaesthetist, Singapore General Hospital)We have a great line up of panelists:Dr Ling Li Min, Infectious Disease Specialist, Private PracticeClin Asst Prof Jansen Koh, Intensivist/Pulmonologist, Changi General HospitalDr Andrea Kwa, Pharmacy Clinician Scientist, Infectious Disease (Pharmacy) Residency & Training Director, Changi General HospitalEpisode...2021-08-2947 minSICM's PodcastTALKSHOW S03E02 Part 1:Decisions in Choosing the Right Antibiotic Treatment for Critical LRTI Infectious during COVID-19 EraSeries 3, Episode 2 of our AMS-SICM Talkshow! "Decisions in Choosing the Right Antibiotic Treatment for Critical LRTI Infectious during COVID-19 Era" Date: 28th August, 2021, Saturday 2:30PMOur Host:Dr Jolin Wong(Intensivist/Anaesthetist, Singapore General Hospital)We have a great line up of panelists:Dr Ling Li Min, Infectious Disease Specialist, Private PracticeClin Asst Prof Jansen Koh, Intensivist/Pulmonologist, Changi General HospitalDr Andrea Kwa, Pharmacy Clinician Scientist, Infectious Disease (Pharmacy) Residency & Training Director, Changi General HospitalEpisode...2021-08-2945 minSICM's PodcastTALKSHOW S03E01 Part 1:Decisions in Choosing right Diagnostic Tests for Managing Patients with LRTI during COVID-19 EraDecisions in Choosing right Diagnostic Tests for Managing Patients with LRTI during COVID-19 EraOur Host:Dr See Kay Choong(Intensivist/Pulmonologist, SICM Vice President, NUHS RCCM HoD)Panelists:Dr Ling Li Min, Infectious Disease Specialist, Mount Elizabeth Novena HospitalDr Tan Thean Yen, Clinical Microbiologist, Changi General HospitalDr Alvin Ng, Intensivist/Pulmonologist, Private Practice, Past President SICMEpisode Sponsors:Biomerieux, Pfizer2021-08-1545 minSICM's PodcastTALKSHOW S03E01 Part 2:Decisions in Choosing right Diagnostic Tests for Managing Patients with LRTI during COVID-19 EraDecisions in Choosing right Diagnostic Tests for Managing Patients with LRTI during COVID-19 EraOur Host:Dr See Kay Choong(Intensivist/Pulmonologist, SICM Vice President, NUHS RCCM HoD)Panelists:Dr Ling Li Min, Infectious Disease Specialist, Mount Elizabeth Novena HospitalDr Tan Thean Yen, Clinical Microbiologist, Changi General HospitalDr Alvin Ng, Intensivist/Pulmonologist, Private Practice, Past President SICMEpisode Sponsors:Biomerieux, Pfizer2021-08-1546 minACEP Frontline - Emergency MedicineTesting...1-2-3...Testing, The Evolution of Viral Respiratory Testing on the Front Lines of EMIs it COVID-19, the flu, or something else? In this episode, Dr. Sean-Xavier Neath joins us to discuss the evolution of diagnostic testing for respiratory infections in the ED, through the COVID-19 pandemic and beyond. This episode is supported by BioMerieux.2021-08-0223 min
Orange County Society of Health-System PharmacistsCareer Paths for Pharmacists Series - Pharmacy is right for me...but now what? - Infectious Diseases and IndustryThe doctor of pharmacy degree (Pharm.D.) is one of the most versatile degrees in healthcare. Most people know about the work of the neighborhood drugstore pharmacist and most people within the profession of pharmacy are aware of clinical positions in inpatient or ambulatory care. But, did you know pharmacists can have full and rewarding careers in settings like industry, managed care, public health, and other unique venues of care? Join us as we explore the explore the unique opportunities within the pharmacy profession!In this episode we take a look at a career within infectious disease...2021-06-1951 minFood Safety MattersbioMerieux: Accelerating Diamond Pet Foods EMPDr. Michele Sayles has over 21 years of experience in Food Safety, Quality, and Food Microbiology. As I mentioned, Michele’s current role is Executive Director of Food Safety and Quality for Diamond Pet Foods. Prior to joining Diamond, Michele was responsible for the Global Food Safety and Microbiology Program at Hill’s Pet Nutrition. She has also held key Food Safety and Quality positions across various industries. She was the Sr. Corporate Quality Assurance & Food Safety Manager for the Sara Lee Corporation; the Director of HACCP and Food Safety for Seaboard Foods; and Director of Pork Safety for the Nationa...2021-05-0646 min
RADEEALFM´Torre de la Salud 05 Febrero 2021Conversaremos con los amigos de Anefar sobre los sitios donde tiene presencia esta asociación de farmacias regionales, dialogamos con el director general de Biomerieux, Héctor Barillas y cerramos con broche de oro platicando con Octavio Caro, director de Ultra Laboratorios. Esto y más con cada uno de nuestros gestores, en el tercer capítulo de Torre de la Salud, R21.
¡Quédate! 2021-02-061h 56
L'Industrie rebondit avec la French FabLe clé du lien de confiance entre grands groupes et PMENous sommes à Aix-les-Bains, en Savoie, au siège d’Infodream : éditeur et intégrateur de logiciel pour la qualité et la maîtrise des processus de fabrication. L’entreprise, née il y a trente ans, a pour clients Airbus, Safran, PSA, Biomérieux, Seb… Alors comment travailler avec des grands groupes ? Gros plan sur la sous-traitance avec sa fondatrice Corinne Clesse.2020-12-0902 min
L'Industrie rebondit avec la French FabLe clé du lien de confiance entre grands groupes et PMENous sommes à Aix-les-Bains, en Savoie, au siège d’Infodream : éditeur et intégrateur de logiciel pour la qualité et la maîtrise des processus de fabrication. L’entreprise, née il y a trente ans, a pour clients Airbus, Safran, PSA, Biomérieux, Seb… Alors comment travailler avec des grands groupes ? Gros plan sur la sous-traitance avec sa fondatrice Corinne Clesse. Voir Acast.com/privacy pour les informations sur la vie privée et l'opt-out.2020-12-0902 minFood Safety MattersbioMerieux: Predictive DiagnosticsAdam Joelsson is Director of Technology and Head of Research and Development at Invisible Sentinel Inc. Having a background in microbiology and molecular biology, Adam joined Invisible Sentinel in 2008 as part of the founding team and has been integral in the development and commercialization of both Veriflow® and veriPRO® molecular diagnostic platforms. As part of the Invisible Sentinel technical team, Adam has overseen the R&D technical transfer and commercial launches of over a dozen rapid assay systems for a wide range of industrial applications, including food safety as well as beverage and food quality. Vik Dutta ha...2020-11-1936 minDebrief BourseLe debrief Bourse du 26 octobre : le CAC 40 plombé par la chute de la techLa combinaison de facteurs pèse sur le moral des investisseurs. Le marché doit en effet se résoudre à l’installation de la seconde vague de l’épidémie de Covid-19 qui rend désormais inéluctable de nouvelles mesures dans les prochains jours …De plus, les investisseurs se font désormais à l’idée qu’un plan de relance aux Etats-Unis ne sera pas adopté avant le scrutin du 3 novembre.Le CAC 40 termine la séance sur une baisse de 1,90 % vers les 4816 points.Du côté des valeurs,2020-10-2602 minSICM's PodcastTALKSHOW S02E03 Part2: MANAGEMENT OF MDRO IN ICU SETTINGS: PART 2: CRE, CRAb, and CRPa29 August, 2020, 14:30hrs SingaporeManagement of MDRO in ICU settings: Part 2: CRE, CRAb, and CRPaHost:- Dr Claudia Tien, Intensivist, Singapore General HospitalGuests:- Dr Koh Yin Ling, Infectious Diseases, Mount Elizabeth Novena Hospital- Dr Loh Jiashen, Infectious Diseases, Seng Kang Hospital- Mr Yeoh Siang Fei, Pharmacist, NUHS1 CME and CPE point accredited.Episode Sponsor: bioMérieux and Pfizer2020-08-3153 minSICM's PodcastTALKSHOW S02E03 Part 1 :MANAGEMENT OF MDRO IN ICU SETTINGS: PART 2: CRE, CRAb, and CRPa29 August, 2020, 14:30hrs SingaporeManagement of MDRO in ICU settings: Part 2: CRE, CRAb, and CRPaHost:- Dr Claudia Tien, Intensivist, Singapore General HospitalGuests:- Dr Koh Yin Ling, Infectious Diseases, Mount Elizabeth Novena Hospital- Dr Loh Jiashen, Infectious Diseases, Seng Kang Hospital- Mr Yeoh Siang Fei, Pharmacist, NUHS1 CME and CPE point accredited.Episode Sponsor: bioMérieux and Pfizer2020-08-3139 minSICM's PodcastTalkshow S02E02 Part1: Management of MDRO in ICU settings: Part 1. MRSA, VRE and ESBLsAug 22, 2020 14:30 SingaporeFor Talkshow 1 of Series 2, the theme is: Management of MDRO in ICU settings: Part 1. MRSA, VRE and ESBLsfeaturing:Host:- Dr. Adrian Kee, NUHSGuests:- Dr. Adrian Ong, Mount Elizabeth Hospital, Private Practice- Dr Lee Tau Hong, Tan Tock Seng Hospital/NCID- Dr Indumathi Venkatachalam, Singapore General Hospital1 CME and CPE point accredited.Episode Sponsor: bioMérieux and Pfizer2020-08-2446 minSICM's PodcastTalkshow S02E02 Part2: Management of MDRO in ICU settings: Part 1. MRSA, VRE and ESBLsAug 22, 2020 14:30 SingaporeFor Talkshow 1 of Series 2, the theme is: Management of MDRO in ICU settings: Part 1. MRSA, VRE and ESBLsfeaturing:Host:- Dr. Adrian Kee, NUHSGuests:- Dr. Adrian Ong, Mount Elizabeth Hospital, Private Practice- Dr Lee Tau Hong, Tan Tock Seng Hospital/NCID- Dr Indumathi Venkatachalam, Singapore General Hospital1 CME and CPE point accredited.Episode Sponsor: bioMérieux and Pfizer2020-08-2444 minSICM's PodcastTalkshow S02E01 Part1: The role of diagnostics in Antimicrobial stewardship in critically ill patientsTitle:The role of diagnostics in Antimicrobial stewardship in critically ill patientsHost:- Dr Kenneth Chan, Private PracticePanelists:- Dr Lee Tau Hong, TTSH/NCID- A/Prof Andrea Kwa, Singapore General Hospital- Dr Piotr Chlebicki, Private PracticeEpisode Sponsors: bioMérieux and Pfizer (unrestricted grant)2020-08-1742 minSICM's PodcastTalkshow S02E01 Part2: The role of diagnostics in Antimicrobial stewardship in critically ill patientsTitle:The role of diagnostics in Antimicrobial stewardship in critically ill patientsHost:- Dr Kenneth Chan, Private PracticePanelists:- Dr Lee Tau Hong, TTSH/NCID- A/Prof Andrea Kwa, Singapore General Hospital- Dr Piotr Chlebicki, Private PracticeEpisode Sponsors: bioMérieux and Pfizer (unrestricted grant)2020-08-1744 min
Le Journal des BiotechsLe Journal des biotechs : Michele Garufi, PDG de Nicox, François Miceli, Sofimac InnovationDans ce numéro du journal des biotechs, François Miceli, senior managing partner chez Sofimac Innoavtion est l'invité du point d'actualité. Sofimac est une société de capital-investissement spécialisée dans les sciences de la vie. Elle lance un nouveau fonds, Pertinence Invest 2, avec une vingtaine d'universités, grandes écoles d'ingénieurs et une dizaine d'industriels, dont Biomérieux. Objectif : développer des start-ups du Deeptech et de la santé (nutrition, santé connectée, diagnostic)L'invité de l'interview est Michele Garufi, PDG de Nicox. Il revient notamment sur l'étude de phase 3 pour NCX 470 mais aussi sur l'évolut...2020-06-2530 min
Harvard Alumni Entrepreneurs InvitesWhen a Harvard Alum is the CEO of Moderna Therapeutics, in the Race for the COVID-19 VaccineTime to market has never been as critical as with the search for the COVID-19 vaccine. Moderna Therapeutics (MRNA), who in December 2018, led the largest biotech IPO in history, is in that race against the clock, deploying a novel technology, messenger RNA. Messenger RNA is also the technology of the company’s platform approach to the development of treatments for potentially 20 diseases and in theory applicable to many more. Being the CEO of a life sciences company working on a technology that has not previously led to an approved vaccine or drug, requires an extra dose of "boldness, curiosity, an...2020-06-2443 min